Have additional questions?
Connect with CSL Behring Medical Affairs to find additional information and ask questions.
Hizentra is indicated for the treatment of primary immune deficiency (PI) in adults and pediatric patients 2 years and older.
Discover the latest innovation in Ig
Consider Hizentra for patients with PI who:
Have venous
access issues
Experience IVIg-related systemic ARs
Clinical Challenges
Want more freedom
and flexibility
Find IVIg infusions inconvenient
Lifestyle Burdens
Photos do not depict actual patients
Annette
Below are areas you may find especially helpful when providing Hizentra to your patients.
Voluntary withdrawal of specific Hizentra vial lots.
Connect with CSL Behring Medical Affairs to find additional information and ask questions.